STOP Bristol-Myers Squibb and ORGANIZATION had a setback DATE in their plans to market a first-of-its-kind diabetes medication that aims to control blood sugar while also lowering cholesterol STOP  ORGANIZATION deferred approval of the drug Pargluva and asked for more information about its cardiovascular safety STOP  The companies said the agency wanted additional information from patient trials completed since Bristol-Myers and ORGANIZATION submitted data in support of their application STOP 